The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Industry has valued at US$ 3.9 billion in 2022 and is anticipated to grow to US$ 5.5 billion by 2030, with sales revenue set to experience a CAGR of 4.3% during the forecast period. based on a recent market investigation by Future Market Insights (FMI). Sepsis, toxic shock …
Category Archives: Healthcare Trends
Arthropod-Borne Infections Testing Market Aims for US$ 1.9 Billion by 2029-FMI Projection
The Arthropod-Borne Infections Testing Market plays a vital role in addressing the global health challenge posed by diseases transmitted by arthropods. This market encompasses diagnostic tools and testing solutions crucial for identifying and managing infections such as Zika virus, dengue fever, and Lyme disease. Arthropod-borne viral infections testing market demand is anticipated to reach a valuation …
Global Medical Face Shield Industry is set to grow at an 11% CAGR, reaching US$ 1.64 Billion by 2030 as per FMI projections
The global medical face shield industry, currently valued at approximately US$ 712.8 million as of 2022, is projected to witness exponential growth, soaring to a staggering US$ 1.64 billion by the end of 2030. This significant rise signifies an impressive Compound Annual Growth Rate (CAGR) of 11.0% between 2022 and 2030, showcasing the escalating demand …
Global Respiratory Pathogen Testing Kits Industry is poised for remarkable growth, estimated to reach US$ 7,136.8 Million by 2033, as per FMI
The global respiratory pathogen testing kits industry is poised for significant expansion, according to the latest research findings from Future Market Insights (FMI). Forecasting a Compound Annual Growth Rate (CAGR) of 5.7% from 2023 to 2033, the market is set to reach a valuation of US$ 7,136.8 million by 2033, escalating from an estimated US$ …
Global Dual and Multi-Energy Computed Tomography (CT) Industry is projected to an impressive US$ 2.6 Billion by 2029 | according to FMI
The global dual and multi-energy computed tomography (CT) industry is poised for remarkable growth, projected to escalate at a staggering Compound Annual Growth Rate (CAGR) of 8.2%. This dynamic surge is anticipated to propel the market from its valuation of US$ 1.5 billion in 2022 to an impressive US$ 2.6 billion by 2029. Dual and …
Global Pneumococcal Testing Industry is expected to hit a valuation of US$ 3.6 Billion by 2030, driven by technological advancements and unmet needs, according to FMI
The global pneumococcal testing industry trends is expected to reach US$ 3.6 billion by 2030, with sales revenue expected to register CAGR of 11.2% over the forecast period. According to a recent industry study by Future Market Insights (FMI). The market is currently estimated to be worth US$ 1.6 billion in 2022. Due to its …
Global Generic Injectable Industry will grow at a CAGR of 11.6%, reaching an estimated worth of US$ 3,22,433.1 Million by 2033 | FMI
The global generic injectable industry share is anticipated to reach US$ 3,22,433.1 million in value by 2033, expanding at a CAGR of 11.6% from 2023 to 2033. In 2023, it is projected that the market will be worth US$ 1,07,419.72 million. The global market for generic injectables is anticipated to reach US$ 85 billion in …
Global Phytopathological Disease Diagnostics Industry is on track to grow at a projected 4.3% CAGR from 2022 to 2029, according to FMI analysis
In 2022, the global phytopathological disease diagnostics industry is anticipated to be valued roughly US$ 97.0 Million. The entire market is estimated to grow at a moderate CAGR of 4.3% between 2022 and 2029, reaching a valuation of US$ 130.6 Million by 2029 due to the growing usage of phytopathological disease diagnostics for the early …
Global PARP Inhibitors Industry, driven by the growing interest in targeted therapy, is anticipated to achieve US$ 8.43 Billion by 2026, according to FMI
The PARP inhibitors industry size is predicted to grow to US$ 5.51 billion by 2022. Due to the increasing demand for sophisticated targeted therapy for the treatment of chronic illnesses like cancer, the market is growing. The market for PARP inhibitors is predicted to surpass US$ 8.43 billion during the projection period of 2022 to …
Global Disposable Spinal Instruments Industry is poised to reach US$ 96.5 Million by 2028, owing to the escalating demand for minimally invasive surgical methods, as identified by FMI
In 2022, the disposable spinal instruments industry size is anticipated to be worth roughly US$ 59.7 Million. The overall demand for disposable spinal tools is anticipated to grow at a strong CAGR of 8.3% between 2022 and 2028, reaching a valuation of US$ 96.5 Million by 2028 due to the growth in hospital acquired infection …